American Roentgen Ray Society Minimally Invasive Musculoskeletal Interventional Oncology Masterclass Bone Metastases and Benign Bone Tumors 2025

• Target Audience: radiologists, interventional oncologists, orthopedic oncologists
• Sample video: contact me for sample video
• Information:

November 3, 2025

Learning Outcomes and Modules

After completing this course, the learner should be able to:

Identify pathology that is appropriate for thermal ablation.

Differentiate between available thermal ablation modalities.

Demonstrate appropriate techniques that achieve safe, effective margins.

The American Roentgen Ray Society (ARRS) – Minimally Invasive Musculoskeletal Interventional Oncology Masterclass: Bone Metastases and Benign Bone Tumors 2025 is best for radiologists, interventional oncologists, orthopedic oncologists, and trainees who want to master image‑guided, minimally invasive techniques for managing bone tumors and metastases. It emphasizes cutting‑edge interventional oncology approaches, diagnostic precision, and multidisciplinary collaboration.

Who Should Attend

Interventional radiologists performing minimally invasive procedures for bone tumors and metastases.

Musculoskeletal radiologists specializing in advanced imaging and intervention.

Residents & fellows in radiology or oncology seeking advanced training in musculoskeletal interventional techniques.

What You’ll Learn

Image‑guided interventions: radiofrequency ablation, cryoablation, cementoplasty, and embolization.

Bone metastases management: pain palliation, stabilization, and local tumor control.

Benign bone tumors: minimally invasive treatment strategies for osteoid osteoma and other lesions.

Multimodality imaging: MRI, CT, and PET for diagnosis and procedural guidance.

Case‑based instruction: real examples of minimally invasive musculoskeletal oncology procedures.

• Topics:

Module 1

Percutaneous Minimally Invasive Thermal Ablation for Management of Vertebral Metastases—Anderanik Tomasian, MD

Thermal Protection: Heightened Safety for Percutaneous Musculoskeletal Tumor Ablations—Daniel Crawford, MD

Extra-Spinal Musculoskeletal Metastases: Role of Minimally Invasive Percutaneous Thermal Ablation—Resten Imaoka, MD

Module 2

Palliative Pain Injections in Interventional Musculoskeletal Oncology—Brian Cusworth, MD

Role of Vertebral Augmentation/Cementation as a Stand-alone Modality for Management of Bone Metastases—Theodore L. Vander Velde, MD

Percutaneous Osteosynthesis for Management of Osseous Metastases—Dimitrios Filippiadis, MD, PHD

Minimally Invasive Percutaneous Interventions for Management of Benign Bone Tumors—Anderanik Tomasian, MD